Biotech Nationhood: How Nations Are Weaponizing Biology

From gene editing to vaccine manufacturing, biotech is becoming a tool of sovereignty.

Biotechnology is no longer just about healthcare and pharmaceuticals. From CRISPR gene editing to vaccine manufacturing and biosecurity platforms, biology is being reimagined as a lever of sovereignty. Nations are pouring capital into labs, infrastructure, and supply chains to secure independence in everything from food systems to pandemic defense. This is a race for resilience and influence, and it is reshaping global markets in real time. For investors, the implications are profound: biotech is becoming not only a growth industry but also a national security asset.

Sign-up to unlock this article and get our latest insights.

Important Disclosure

The views expressed are those of the author(s) and do not necessarily reflect the views of Filion Capital or its affiliates. Opinions are based on current market conditions and may change without notice. Filion Capital, its affiliates, and employees may hold positions, trade, or provide services related to the securities or strategies discussed, which may change without notice. This material is for informational purposes only and is not an offer or solicitation to buy or sell any securities or strategies. It does not constitute investment, legal, accounting, or tax advice. Investors should consult their own advisers before making decisions. Information is believed to be reliable but is not guaranteed for accuracy or completeness. Filion Capital is not liable for losses arising from its use. Past performance does not guarantee future results. All investments carry risk, including potential loss of principal.